Neurocrine biosciences supports mental health month and tardive dyskinesia awareness week

San diego, may 3, 2021 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) today announced its support of mental health month and commitment to raising awareness of and supporting people living with tardive dyskinesia (td). some people living with a mental health condition may also experience td, an involuntary movement disorder that may develop after a few months of taking certain medications to treat bipolar disorder, depression and schizophrenia.1-3 the uncontrollable movements of td, which can affect the face, torso and/or other body parts, may be disruptive to people's lives due to the symptoms and impact on their physical, emotional and social well-being.1,2,4 to help raise awareness of td, the mental health advocacy community and states across the country are recognizing the first full week of may (2-8) as tardive dyskinesia awareness week for the fourth year in a row.
NBIX Ratings Summary
NBIX Quant Ranking